ORPHAZYME A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,049 DKK | -0.81% |
|
+3.88% | -21.11% |
| 27/03 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 04/03 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORPHAZYME A/S | Bio Therapeutic Drugs | -0.81% | +3.88% | -21.11% | -12.57% | -98.04% | 5.4M |  |  | |
- Stock Market
- Equities
- ORPHA Stock
- Charts Orphazyme A/S
- Relative Strength Chart
